EMA publishes new plan to support antibiotic development

Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
Photo: Peter Dejong/AP/Ritzau Scanpix
Photo: Peter Dejong/AP/Ritzau Scanpix
by christian bundgaard, translated by daniel pedersen

The European Medicines Agency (EMA) has a plan to address the increasingly pressing challenge of antibiotic-resistant bacteria, the EMA reports in a news release on its website.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading